Del. Jurors Clear Oxford Nanopore In DNA Tech Patent Suit

Law360 (March 18, 2020, 1:23 PM EDT) -- A federal jury in Delaware cleared Oxford Nanopore Technologies Inc. on Wednesday of claims that some of its DNA analysis technology and devices — used in early coronavirus investigations in China — infringed four patents held by Pacific Biosciences of California Inc.

The decisions came at the end of a nearly seven-day trial, with jurors deliberating Tuesday and much of Wednesday morning before returning with a complex verdict that nevertheless cleared Oxford of any liability for damages.

Although Oxford was found to have infringed three of four patents, the jury also found that all three claims for those three patents-in-suit were...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!